|Articles|July 1, 2019
- BioPharm International-07-01-2019
- Volume 32
- Issue 7
BioPharm International, July 2019 Issue (PDF)
Click the title above to open the BioPharm International July 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
FDA Revamps Biosimilar Quality Requirementsover 6 years ago
Playbooks Are Not Just Child’s Playover 6 years ago
Applying QbD to Upstream Processingover 6 years ago
A Biologics Partisan Divideover 6 years ago
Analysis of Residual Impurities in Continuous Manufacturingover 6 years ago
Gene Therapies Propel Outsourcing Investmentover 6 years ago
Removing Gaps in Data Integrityover 6 years ago
Catching Up DownstreamNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
3
Developing Next-Gen Cell Lines Using Targeted Integration
4
FAQ: Shifts in FDA Regulations and Strategies in 2025
5
